Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by josameyeron Nov 02, 2010 2:43pm
480 Views
Post# 17646393

Hedge reduction $21-000-000

Hedge reduction $21-000-000Reduced hedge by 43276 ounces at a cost of $21 000-000.The original forward gold sales contract is based on the average price $876.Gold currently is trading at $1356.30.We will not know what the price of gold  will be, come January 1 through the end of Sept . until that time has come.However, if you take a projection how much gold we will produce, or how much we can sell from Jan 1 through Sept. Taking the current price and subtract the hedged price, I think you come up with about a difference of $480  per ounce.That amount  multiplied by the number of unhedged ounces sold. will go back to Brigus coffers  plus of course the difference of the cost  of a ounce of gold produced and the $876 hedge price  as I understand it.I am not sure that the amount of ounces of gold  that can be sold from Jan1 through Sept is capped. Because if you take the given reduced hedge figure of 43276 and multiply that by 480, you will get a figure of $ 20-772-480.I stand corrected If I am in error.Any Ideas?. The forgoing is my opinion only.  Please DYODD .Cheers to all. Josa.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse